Prevention can lead to the rejection of a cancer diagnosis

Published Date: 13 Mar 2023

Some adults do not consider the importance of testing, while others believe that a healthy diet with regular bowel movements does not require testing, according to the study.

Read Full News

Latest News



Todays Updates


NeurologyLive® Friday 5 — February 6, 2026 Isabella Ciccone, MPH


Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 6, 2026.

Comparative Study Reveals Psychiatric Comorbidities Common in MOGAD, MS, and NMOSD, With Distinct Timing Patterns Isabella Ciccone, MPH


A new comparison study of patients with autoimmune diseases reported high rates of anxiety and depression, with notable differences in when psychiatric symptoms emerged relative to disease onset.

Cladribine Tablets Reduce Treatment Switches, Outpatient Visits, and Health Care Costs in Multiple Sclerosis Isabella Ciccone, MPH


A real-world study showed that cladribine tablets were associated with greater treatment persistence and lower health care costs in patients with multiple sclerosis compared with other common therapies.

Innovative Trial Employs Novel PET Imaging to Track Cladribine’s Effect on Microglial Activation Louie Pasculli


The single-arm CLAD-MAPET study is evaluating whether cladribine tablets reduce microglial activation, captured by [F-18]PBR06-PET, in patients with MS experiencing progression without relapse or MRI activity on anti-CD20 therapy.

Delay Discounting Fails to Predict MDD Relapse, Q&A With Giles Story, PhD


Delay Discounting Fails to Predict MDD Relapse, Q&A With Giles Story, PhD

The HCPFive: Top News for Healthcare Providers from the Week of 02/01


The HCPFive: Top News for Healthcare Providers from the Week of 02/01

HCPLive 5 Stories in Under 5: Week of 02/01


HCPLive 5 Stories in Under 5: Week of 02/01

Todays Updates


NeurologyLive® Friday 5 — February 6, 2026 Isabella Ciccone, MPH


Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 6, 2026.

Comparative Study Reveals Psychiatric Comorbidities Common in MOGAD, MS, and NMOSD, With Distinct Timing Patterns Isabella Ciccone, MPH


A new comparison study of patients with autoimmune diseases reported high rates of anxiety and depression, with notable differences in when psychiatric symptoms emerged relative to disease onset.

Cladribine Tablets Reduce Treatment Switches, Outpatient Visits, and Health Care Costs in Multiple Sclerosis Isabella Ciccone, MPH


A real-world study showed that cladribine tablets were associated with greater treatment persistence and lower health care costs in patients with multiple sclerosis compared with other common therapies.

Innovative Trial Employs Novel PET Imaging to Track Cladribine’s Effect on Microglial Activation Louie Pasculli


The single-arm CLAD-MAPET study is evaluating whether cladribine tablets reduce microglial activation, captured by [F-18]PBR06-PET, in patients with MS experiencing progression without relapse or MRI activity on anti-CD20 therapy.

Delay Discounting Fails to Predict MDD Relapse, Q&A With Giles Story, PhD


Delay Discounting Fails to Predict MDD Relapse, Q&A With Giles Story, PhD

The HCPFive: Top News for Healthcare Providers from the Week of 02/01


The HCPFive: Top News for Healthcare Providers from the Week of 02/01

HCPLive 5 Stories in Under 5: Week of 02/01


HCPLive 5 Stories in Under 5: Week of 02/01

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Having a tattoo could increase your risk of developing lymphoma.

2.

An individual state lost $4.02 billion due to untreated mental illness.

3.

Novel biomarker has potential for predicting and treating skin cancer metastasis

4.

Adopted cancer cells and the effects of their presence.

5.

A new therapeutic approach could help tackle radiation resistance in childhood brain tumors


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot